GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cencora Inc (STU:ABG) » Definitions » Cyclically Adjusted PS Ratio

Cencora (STU:ABG) Cyclically Adjusted PS Ratio : 0.21 (As of Jun. 01, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Cencora Cyclically Adjusted PS Ratio?

As of today (2024-06-01), Cencora's current share price is €205.30. Cencora's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €955.58. Cencora's Cyclically Adjusted PS Ratio for today is 0.21.

The historical rank and industry rank for Cencora's Cyclically Adjusted PS Ratio or its related term are showing as below:

STU:ABG' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.14   Med: 0.19   Max: 0.39
Current: 0.22

During the past years, Cencora's highest Cyclically Adjusted PS Ratio was 0.39. The lowest was 0.14. And the median was 0.19.

STU:ABG's Cyclically Adjusted PS Ratio is ranked better than
66.67% of 66 companies
in the Medical Distribution industry
Industry Median: 0.38 vs STU:ABG: 0.22

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Cencora's adjusted revenue per share data for the three months ended in Mar. 2024 was €312.865. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €955.58 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Cencora Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Cencora's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cencora Cyclically Adjusted PS Ratio Chart

Cencora Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.15 0.16 0.15 0.18

Cencora Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 0.20 0.18 0.20 0.23

Competitive Comparison of Cencora's Cyclically Adjusted PS Ratio

For the Medical Distribution subindustry, Cencora's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cencora's Cyclically Adjusted PS Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Cencora's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cencora's Cyclically Adjusted PS Ratio falls into.



Cencora Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Cencora's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=205.30/955.58
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cencora's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Cencora's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=312.865/131.7762*131.7762
=312.865

Current CPI (Mar. 2024) = 131.7762.

Cencora Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 98.952 100.560 129.670
201409 104.299 100.428 136.856
201412 124.127 99.070 165.106
201503 137.060 99.621 181.299
201506 126.967 100.684 166.176
201509 149.022 100.392 195.610
201512 148.638 99.792 196.277
201603 142.192 100.470 186.498
201606 146.016 101.688 189.220
201609 147.496 101.861 190.814
201612 163.008 101.863 210.878
201703 157.005 102.862 201.138
201706 155.266 103.349 197.973
201709 148.304 104.136 187.668
201712 154.849 104.011 196.185
201803 149.699 105.290 187.357
201806 167.285 106.317 207.344
201809 170.638 106.507 211.123
201812 186.475 105.998 231.825
201903 180.360 107.251 221.604
201906 189.603 108.070 231.195
201909 193.725 108.329 235.655
201912 207.589 108.420 252.308
202003 207.247 108.902 250.779
202006 195.995 108.767 237.456
202009 204.864 109.815 245.834
202012 208.745 109.897 250.304
202103 199.163 111.754 234.845
202106 212.179 114.631 243.913
202109 237.524 115.734 270.447
202112 249.903 117.630 279.958
202203 247.224 121.301 268.574
202206 268.356 125.017 282.865
202209 294.301 125.227 309.694
202212 287.541 125.222 302.592
202303 290.170 127.348 300.260
202306 302.347 128.729 309.505
202309 317.536 129.860 322.223
202312 328.264 129.419 334.242
202403 312.865 131.776 312.865

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cencora  (STU:ABG) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Cencora Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Cencora's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cencora (STU:ABG) Business Description

Traded in Other Exchanges
Address
1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the U.S. pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.